Updated Dec 4, 2007 at 5:28 EST.
Plethora solutions is a pharmaceutical company who develops and markets products for the treatment of premature ejaculation, erectile dysfunction, urinary incontinence and much more.
Although the company is mostly recognized for their ( PE ) drugs they are developing, they are also gaining recognition for their urinary incontinence treatment PSD03.
The treatment just proved positive clinical results in their preliminary analysis of phase two data.
PSD03 has the potential to be a leading therapy for stress urinary incontinence ( SUI ).
This is characterized by involuntary urine leakage when the patient does anything from sneezing, coughing, laughing or even sitting.
Unfortunately these symptoms are very common and affect more than half of the urinary incontinence sufferers under the age of 50.
Besides PSD03, Plethora solutions is also developing a topical agent (
PSD502 ) for the treatment of PE which is about to enter Phase III clinical trials.
They are also developing a medical device (
SAM™: PSD401 ) in order to objectively evaluate premature ejaculation.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
